Comparison between Paramount Syntex IPO and Q-Line Biotec IPO.
Paramount Syntex IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Q-Line Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of Paramount Syntex IPO is up to ₹0.00 Cr whereas the issue size of the Q-Line Biotec IPO is up to ₹203.74 Cr. The final issue price of Paramount Syntex IPO is and of Q-Line Biotec IPO is ₹343.00 per share.
| Paramount Syntex IPO | Q-Line Biotec IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹326.00 per share | |
| Issue Price (Upper) | ₹343.00 per share | |
| Issue Price (Final) | ₹343.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 400 shares | |
| Fresh Issue Size | 65,00,000 shares | 59,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹203.74 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 65,00,000 shares | 59,40,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹203.74 Cr |
Paramount Syntex IPO opens on , while Q-Line Biotec IPO opens on May 21, 2026. The closing date of Paramount Syntex IPO and Q-Line Biotec IPO is , and May 25, 2026, respectively.
| Paramount Syntex IPO | Q-Line Biotec IPO | |
|---|---|---|
| Anchor Bid Date | May 20, 2026 | |
| Issue Open | May 21, 2026 | |
| Issue Close | May 25, 2026 | |
| Basis Of Allotment (Tentative) | May 26, 2026 | |
| Initiation of Refunds (Tentative) | May 27, 2026 | |
| Credit of Share (Tentative) | May 27, 2026 | |
| Listing date (Tentative) | May 29, 2026 | |
| Anchor Lockin End date 1 | Jun 25, 2026 | |
| Anchor Lockin End date 2 | Aug 24, 2026 |
Paramount Syntex IPO P/E ratio is , as compared to Q-Line Biotec IPO P/E ratio of 20.82.
| Paramount Syntex IPO | Q-Line Biotec IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.74 | 96.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹800.16 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹16.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Paramount Syntex IPO Retail Individual Investors (RII) are offered 0 shares while in Q-Line Biotec IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Paramount Syntex IPO and 11,88,000 shares in Q-Line Biotec IPO.
| Paramount Syntex IPO | Q-Line Biotec IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 17,81,200 shares |
| Market Maker Reservation | 0 shares | 3,13,200 shares |
| QIB | 0 shares | 11,88,000 shares |
| NII | 0 shares | 8,91,600 shares |
| RII | 0 shares | 20,79,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 59,40,000 shares |
Paramount Syntex IPO subscribed in total, whereas Q-Line Biotec IPO subscribed 71.71x.
| Paramount Syntex IPO | Q-Line Biotec IPO | |
|---|---|---|
| QIB (times) | 123.94x | |
| NII (times) | 145.98x | |
| Big NII (times) | 178.29x | |
| Small NII (times) | 81.35x | |
| RII (times) | 71.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 71.71x |
